GW-5074

N/A

Report date: 2025/12/19 15:55:35
NME

Base Information

Drug NameGW-5074
Drug Alias NameGW-5074MG-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-Raf kinase inhibitors
TargetsC-Raf kinase
Therapy Area/IndicationsSolid tumoursNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMetagone Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumoursNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A